Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Classement en actions #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Prix de l'action
$3.78
Dernière synchronisation: 2026-03-17
Capitalisation boursière
$276.54M
Changement (1 jour)
0.00%
Changement (1 an)
45.53%
Pays
CA
Échange NervGen Pharma Corp. (NGEN)

Catégorie

Historique du prix de l'action pour NervGen Pharma Corp. (NGEN)
Prix de clôture le plus élevé : $3.98 le 2026-03-01

Prix de clôture le plus bas : $1.12 le 2019-03-01
Historique du prix de l'action de NervGen Pharma Corp. de 2019 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.24 -10.01%
AU
$748.60 6.90%
CH